As a rule, such a tumor develops at a young age (BRCA1-related, at 35–39 years old; BRCA2-related, at 43–54 years old) and characterized by hormone-independent growth, high rate of development in the opposite gland, high degree of malignancy, tendency to relapse, and worse prognosis [25]. This evidence concerns the gene BRCA2 and neoplasm.